Colorectal Cancer Update - Surgeons 2 2006

You are here: Home: CCU for Surgeons 2 | 2006: CME Information

Colorectal Cancer Update for Surgeons
A Continuing Medical Education Audio Series

STATEMENT OF NEED / TARGET AUDIENCE

Colorectal cancer is one of the most rapidly evolving fields in oncology. Published results from a plethora of ongoing clinical trials lead to the continuous emergence of new therapeutic techniques, agents and changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing colorectal cancer surgeon must be well informed of these advances. To bridge the gap between research and patient care, Colorectal Cancer Update for Surgeons utilizes one-on-one discussions with leading colorectal cancer investigators. By providing access to the latest research developments and expert perspectives, this CME program assists colorectal surgeons in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES

Critically evaluate the clinical implications of emerging clinical trial data in colorectal cancer treatment in order to incorporate these data into local and systemic management strategies in the neoadjuvant, adjuvant and metastatic disease settings.
Counsel appropriately selected patients about the availability of ongoing clinical trials.
Evaluate the emerging research data on various adjuvant chemotherapy approaches, including the use of oxaliplatin-containing regimens and the use of capecitabine or intravenous 5-FU.
Evaluate emerging research data on various neoadjuvant radiation therapy/chemotherapy approaches for rectal cancer and explain the absolute risks and benefits of these regimens to patients.
Describe and implement an algorithm for medical and radiation oncology referral for appropriately selected patients with colorectal cancer for consideration of systemic therapy.
Describe the risks and benefits of various surgical approaches to isolated metastases of colorectal cancer.
Assess the number of resected lymph nodes required to adequately determine the risk of recurrence in patients with colon cancer.

PURPOSE OF THIS ISSUE OF COLORECTAL CANCER UPDATE FOR SURGEONS

The purpose of Issue 2 of Colorectal Cancer Update for Surgeons is to support these global objectives by offering the perspectives of Drs Wexner, Meropol, Roh and Hoff on the integration of emerging clinical research data into the management of colorectal cancer.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

HOW TO USE THIS CME ACTIVITY

This CME activity contains both audio and print components. To receive credit, the participant should listen to the CDs, review the CME information and complete the Post-test and Evaluation Form located in the back of this book or on our website, ColorectalCancerUpdate.com/Surgeons.